3 YEARS IN, PROGRAM BUILDS ON CAPABILITY AND CONNECTIVITY FOR EARLY CAREER RESEARCHERS IN ENT MEDICAL DEVICES Beyond Science gives in theatre opportunities, networking with stakeholders and support from mentors
With
Professor Payal Mukherjee, Adult and Paediatric ENT Surgeon
Otologist, Cochlear Implant and Skull Base Surgeon &
Clinical Professor, Macquarie University &
TGA Advisory Committee for Medical Devices &
Clinical Associate Professor, University of Sydney &
Surgical Innovation Lead, RPA Institute of Academic Surgery &
Head of Department ENT, Sydney Adventist Hospital &
Co-Founder & Co-Director, Beyond Science
Distinguished Professor Gordon Wallace AO,
Director, Intelligent Polymer Research Institute,
University of Wollongong &
Co-Founder & Co-Director, Beyond Science
AUSTRALIAN HEALTH JOURNAL SEGMENT
Filmed in Sydney & Wollongong | August 2025
Surgeon-scientists and surgeon-innovators have an important role in the entire medical technology translational cycle; not only from discovery to commercialisation, but in ensuring that health technologies are implemented in value-based manner.
This includes defining safety and regulatory standards, balancing patient outcomes against health care costs, and working with policy makers to ensure that funding is both sustainable and promotes equitable access to technology.
Despite a rich history of biomedical innovation in Australia, there are limited training opportunities for surgeons to develop these skills. Within NSW, there are no formal surgeon-scientist training pathways in Otolaryngology, Head and Neck Surgery.
In 2022, Distinguished Professor Gordon Wallace AO and Professor Mukherjee jointly established Beyond Science as a clinician led, academically supported and clinician run Australian-first medical technology translation program.
The program is aimed at early career researchers and clinician-scientists working in medical device research specifically in otolaryngology (ear, nose, and throat), head and neck surgery.
Its core mission is to build capability and foster connections between researchers and key stakeholders such as industry, government, universities, and health systems.
This is through helping researchers understand health system priorities and translation pathways from research to real-world impact. Uniquely, this includes opportunity to enter surgical environments for observation and tissue collection.
Australian Health Journal spoke to its founders about how it supports academic mentorship and creates networking opportunities to help early career stage medical device researchers connect with clinicians, policymakers, industry leaders, and funding bodies.
Beyond Science is funded by Passe & Williams Foundation & the Sydney Local Health District
Source: Adapted from Beyond Science, RACS and University of Wollongong websites
-
Indigenous physio leadership
On the eve of NAIDOC week 2023, Australian Health Journal met with Scott Willis, the National President of the Australian Physiotherapy Association, a proud Palawa man and the first Indigenous President of the Australian health peak body.
-
State of private healthcare in Australia
Australia’s healthcare system is often described as a mixed system, with a combination of public and private providers. While public healthcare through Medicare provides universal coverage for essential services, private healthcare offers additional options and amenities for those who can afford them.
Private Healthcare Australia (PHA) is the Australian private health insurance industry’s peak representative body that currently has 21registered health funds throughout Australia and collectively represents 98% of people covered by private health insurance. PHA member funds today provide healthcare benefits for over 14 million Australians.
-
Reporting on Australian childhood visual impairment: the first 10 years
The Australian Childhood Vision Impairment Register (ACVIR), the first of its kind in Australia, captures uniquely Australian data which is used to improve services for children with vision impairment. The data is also available to researchers who work in the area of eye disease and disorders of vision.
